300888 Winner Medical
- 31.26
- -0.24-0.76%
Winner Medical News
What is the current inventory status of epidemic prevention products? Plans to open offline stores this year? Robust medical response
Gelonghui, May 10 | On “Current Inventory Status of Epidemic Prevention Products?” Problem, Robust Healthcare recently stated at a performance briefing that in 2023, the company took various measures and carried out extensive work around reducing production capacity, removing inventory, restructuring, and reducing value. Up to now, the vast majority of inventory and remaining issues of epidemic prevention products have been resolved. Currently, infection protection products are mainly sold with flat masks. There is still normal demand in the market, and the business base still exists. From a profit level perspective, the gross margin of infection protection products is definitely lower than in 2023. However, the company continues to improve the level of automation through product innovation, cost reduction and efficiency
Express News | Robust healthcare: maintain the pace of opening around 100 stores every year in the cotton era for the next 3-5 years
Steady Healthcare (300888.SZ) received a total increase of 1391,000 shares from a number of directors and supervisors
Robust Healthcare (300888.SZ) announcement, company director, deputy general manager and financial director Fang Xiuyuan, director Xu Xiaodan...
Robust Healthcare (300888.SZ): Repurchase completed, 0.987% of shares have been repurchased
Gelonghui, May 6, 丨 Robust Healthcare (300888.SZ) announced that as of April 29, 2024, the company had repurchased 5,807,900 shares of the company through a dedicated securities account, accounting for 0.9872% of the company's total share capital. The highest transaction price was 39.79 yuan/share, the minimum transaction price was 29.25 yuan/share, and the total transaction amount was 195 million yuan (excluding transaction fees). The implementation of this share repurchase plan has been completed.
Steady Healthcare (300888): Multi-channel deep collaboration to grow beautifully in the consumer goods business
Guide to this report: The pressure on the company's 2023 performance was mainly affected by the decline in demand for infection protection products, but the consumer goods business still achieved steady growth. It is expected that along with the optimization of store floor efficiency, the performance is expected to grow steadily. Investment Highlights: Conclusion: Consider the Public
Steady Healthcare (300888): Cotton brands show resilience in stabilizing, moderating, and improving routine medical business
Performance summary: The company released its 2023 annual report and 2024 quarterly report. In 2023, the company achieved revenue of 8.19 billion yuan, -27.9% year on year; realized net profit of 580 million yuan, -64.8% year on year; realized deductions
Steady Healthcare (300888): Net profit fell 51.6% in 1Q24, and subsequent growth is expected to recover steadily
The 2023 results are lower than market expectations. The 1Q24 results are basically in line with our expectations. The company announced the 2023 and 1Q24 results, and the 2023/1Q24 revenue reached 81.9/1.91 billion yuan respectively.
Steady Healthcare (300888): Short-term performance is pressured by steady improvement in the quality of consumer goods business operations
According to the company's announcement, revenue in 2023 was -28% YoY/Performance -65% YoY. In 2023, the company's revenue was 8.19 billion yuan, -28% year on year; performance was 580 million yuan, -65% year on year (significant year-on-year decrease in performance
Steady Healthcare (300888): High quality growth in the consumer goods business, short-term pressure on the medical business under high base
Key investment points: The company released its 2023 annual report and 2024 quarterly report. Revenue performance was in line with expectations, and profits fluctuated in the short term due to the high base of epidemic prevention supplies. 1) The company's revenue in 2023 was 8.19 billion yuan, a year-on-year decrease of 2
Steady Healthcare (300888): Performance differentiation of medical consumables and consumer goods is expected to return to steady growth
Revenue and net profit attributable to mother in '23 were -28% and -65% year-on-year, 19%, and -52% year-on-year in 24Q1. Short-term performance was under pressure, and steady healthcare published its 2023 annual report and 2024 quarterly report. Company 2023
Steady Healthcare (300888.SZ) announced its 2023 annual results, net profit of 580 million yuan, a year-on-year decrease of 64.84%
Robust Healthcare (300888.SZ) released its 2023 annual results report. The company achieved operating income during the reporting period...
Steady Healthcare (300888.SZ) has repurchased a total of 0.71% of its shares at a cost of 145 million yuan
Robust Healthcare (300888.SZ) announced that as of March 31, 2024, the company had repurchased a total of 41 shares...
Steady Healthcare (300888): Release of a plan to improve both quality and return, and the medical and consumer businesses can be expected to grow rapidly together
The company's recent situation Recently, the company announced the “Action Plan for Double Improvement of Quality and Return”, clarifying the company's confidence in the development of its main business and shareholder returns. Since the company went public in 2020, it has continued to increase shareholder returns, using cash for the past three years
Steady Healthcare (300888.SZ) has repurchased a total of 3.635,900 shares at a cost of 125 million yuan
Robust Healthcare (300888.SZ) announced that as of February 29, 2024, the company is using centralized bidding transactions...
Express News | Robust Healthcare traded 7 million shares at a discounted price today, with a turnover of 251 million yuan
Robust Healthcare (300888.SZ): Initial repurchase of 646,600 shares involving 1999.92 million yuan
Gelonghui, Feb. 2 | Robust Healthcare (300888.SZ) announced that on February 2, 2024, for the first time, the company repurchased 646,600 shares of the company's shares through a dedicated securities account, accounting for 0.1088% of the company's total share capital. The highest transaction price was 31.91 yuan/share, the minimum transaction price was 30.01 yuan/share, and the total transaction amount was 1999.92 million yuan (not including transaction fees).
Steady Healthcare (300888) Review: Improving the quality and efficiency of the consumer goods business, medical business 24 young people enter the market
Key investment points: The company released a 2023 performance forecast and is expected to achieve net profit of 68-80 million yuan for the whole year. In 2023, the company expects to achieve operating revenue of 80.6-8.26 billion yuan, a year-on-year decrease of 27.2% -29.
Steady Healthcare (300888.SZ): In 2023, store operating efficiency improved, and store floor efficiency increased by about 15% year-on-year
Gelonghui, Feb. 1 | Steady Healthcare (300888.SZ) revealed that in 2023, store operating efficiency improved, and store floor efficiency achieved a year-on-year increase of about 15%, mainly in the following areas of work: First, we selected the store type. According to the different store types, we made more detailed plans, appropriately adjusted and reduced the types of large stores that needed to be improved in efficiency, and expanded potential store types with better profitability under 300 square meters. Second, in terms of quality and efficiency, digital management has been strengthened, focusing on explosive products, and displayed around three major scenarios to reduce the delay of long-tail SKUs
Steady Healthcare (300888.SZ): In the 2023 Cotton Era, the number of members increased by 9.08 million, an increase of 16% year-on-year
Gelonghui Feb. 1 | Robust Healthcare (300888.SZ) revealed a record sheet of investor relations activities, showing that judging from the 2023 operating results, market performance is more of a trend where consumption is stratified, and consumers are becoming more and more refined. The number of members in the 2023 Cotton Era increased by 9.08 million, an increase of 16% over the previous year; the total number of high-value members spending more than 2,000 yuan a year, the member repurchase rate, and the average monthly membership consumption frequency have all increased, which can be seen as an increase in overall membership stickiness. On the other hand, due to consumer prudence, consumers' mentality to stock up weakens, and they will buy in installments, and the customer unit price will be affected as a result
Steady Healthcare (300888) Company Review: Consumer business reduces costs and increases efficiency, and conventional medical consumables grow steadily
The company released a performance forecast, and the net profit for 2023 is expected to be 680 million yuan to 80 million yuan. The company released a performance forecast: 1) Revenue: 2023 revenue is expected to be 80.6 to 8.26 billion yuan, a year-on-year decline of 29% ~
Analysis
Price Target
No Data
